Buchang Pharma's subsidiary completes equity transfer registration

Luzhou Buchang, a subsidiary of Shandong Buchang Pharmaceuticals (SSE:603858), has completed the industrial and commercial change registration following the proposed equity transfer detailed earlier this year. Sichuan Tianrunyuan Enterprise Management Co., Ltd. transferred its 2% stake in Luzhou Buchang to Hainan Qi Hongsheng Enterprise Management Partnership (Limited Partnership) for a consideration of CNY 8.8 million, with Shandong Buchang relinquishing its priority acquisition rights. As a result, Shandong Buchang Pharmaceuticals maintains its 96.8636% stake in Luzhou Buchang, while Hainan Qi Hongsheng now holds 2%. The updated registered capital of Luzhou Buchang remains at CNY 440 million.